Concord Medical Services Holdings Limited CCM
As ofNov 19, 2026, 3:59 PM EST
- YTD
- -6.99%
- 1 year
- -5.28%
5D +0.13 (+3.62%)
- Market cap
- 15.59M
- Revenue (ttm)
- 471.70M
- Profit margin
- -80.33%
- EPS (ttm)
- -2.96
- Shares out
- 2.82M
- Forward P/E
- -30.00
- YTD return
- -6.99%
- 1-year return
- -5.28%
- Volume
- 21.49K
- Avg volume
- 23.66K
- Open
- 3.51
- Previous close
- 3.61
- Day's range
- 3.40 – 3.79
- 52-week range
- 2.79 – 6.80
- Beta
- -0.27
- 50-day average
- 5.90
Key statistics
- 200-day average
- 6.53
- Enterprise value
- 7.88B
- Price / sales
- 0.04
- Revenue growth
- -23.10%
- Total cash
- 326.90M
- Total debt
- 3.56B
- Return on equity
- -32.40%
Fundamental scorecard
5 of 25 checks passed on CCM’s reported financials
5of 25 checks passed
- Value 1 of 5
- Growth 3 of 5
- Profitability 1 of 5
- Financial health 0 of 5
- Dividend 0 of 5
Statements to Dec 31, 2025.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Apr 29, 2019 | Dec 1, 2018 | 0.01 | — | — | — |
| May 7, 2018 | Dec 1, 2017 | -0.06 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 23, 2012 | Morgan Stanley | main | — | Overweight |
| Jul 6, 2012 | Morgan Stanley | main | — | Overweight |
| Mar 22, 2012 | JP Morgan | main | — | Overweight |
About Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- China
- Website
- concordmedical.com
News
Your note
Sign in to keep a note on CCM — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rhumbline Advisers | 0.09% | 2,460 | 11.07K | Sep 29, 2024 |
| UBS Group AG | 0.03% | 923 | 4.15K | Sep 29, 2024 |
